[Form 4] KLA Corporation Insider Trading Activity
Ahmad A. Khan, an officer of KLA Corporation (KLAC), reported a sale of 13,716 shares of KLA common stock on 08/29/2025 at a reported price of $881.5 per share. The filing states the sale was executed under a Rule 10b5-1 trading plan adopted on May 30, 2025. After the reported transaction the filing shows beneficial ownership of 27,372.252 shares, which the filer says includes 21,716.968 shares issuable upon vesting of restricted stock units (RSUs). The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/02/2025.
- Sale executed under a Rule 10b5-1 trading plan, adopted May 30, 2025, indicating the transaction was pre-planned
- Filing discloses post-transaction beneficial ownership and RSU component (21,716.968 shares) providing transparency
- Insider disposed of 13,716 shares on 08/29/2025 at a reported price of $881.5 per share
- Majority of remaining reported holdings are RSUs (21,716.968 of 27,372.252 shares), indicating limited immediately liquid ownership
Insights
TL;DR: Officer sold shares under a pre-established 10b5-1 plan; remaining position largely composed of unvested RSUs.
The reported sale of 13,716 shares at $881.5 per share was executed pursuant to a Rule 10b5-1 plan adopted May 30, 2025, which indicates the transaction was pre-planned and intended to provide an affirmative defense under Rule 10b5-1. The post-transaction beneficial ownership is 27,372.252 shares, disclosed to include 21,716.968 RSU-issuable shares, implying much of the reported holdings are contingent on vesting. For investors, this is a routine insider liquidity event rather than a spontaneous market signal, as explicitly stated in the filing.
TL;DR: Transaction follows governance best practice of using a documented 10b5-1 plan; disclosure is complete for reported items.
The Form 4 discloses the officer relationship, the date the 10b5-1 plan was adopted, the number of shares sold, the sale price, and the composition of remaining beneficial ownership including RSUs. The filing was executed via attorney-in-fact signature, consistent with procedural norms. Based solely on the disclosed facts, this filing reflects compliance with Section 16 reporting obligations and use of an established trading plan rather than ad hoc insider trading.